Creative Planning - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 143 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
Creative Planning ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$778,000
+67.7%
128,9760.0%0.00%0.0%
Q3 2019$464,000
+34.1%
128,9760.0%0.00%
+100.0%
Q2 2019$346,000
-9.4%
128,9760.0%0.00%0.0%
Q1 2019$382,000
+107.6%
128,976
+11.7%
0.00%0.0%
Q4 2018$184,000
-58.2%
115,476
-3.3%
0.00%
-50.0%
Q3 2018$440,000
+30.2%
119,4760.0%0.00%
+100.0%
Q2 2018$338,000
-23.7%
119,4760.0%0.00%
-50.0%
Q1 2018$443,000
+19.1%
119,476
-7.5%
0.00%0.0%
Q4 2017$372,000
-46.9%
129,176
-17.2%
0.00%
-33.3%
Q3 2017$701,000
-2.0%
156,076
+0.2%
0.00%
-25.0%
Q2 2017$715,000
+9.2%
155,830
+0.2%
0.00%0.0%
Q1 2017$655,000
+4.0%
155,576
+2.0%
0.00%0.0%
Q4 2016$630,000
-50.6%
152,576
-3.1%
0.00%
-50.0%
Q3 2016$1,275,000
+22.7%
157,451
+18.2%
0.01%0.0%
Q2 2016$1,039,000
+1.9%
133,175
+0.8%
0.01%0.0%
Q1 2016$1,020,000
+63.7%
132,175
+129.1%
0.01%
+60.0%
Q4 2015$623,000
+142.4%
57,700
+55.1%
0.01%
+150.0%
Q3 2015$257,000
-9.2%
37,200
+16.4%
0.00%
-33.3%
Q2 2015$283,000
-16.5%
31,970
-7.1%
0.00%0.0%
Q1 2015$339,000
+19.4%
34,409
+46.4%
0.00%0.0%
Q4 2014$284,000
-45.4%
23,500
-55.7%
0.00%
-50.0%
Q3 2014$520,000
+352.2%
53,000
+152.4%
0.01%
+200.0%
Q2 2014$115,000
+139.6%
21,000
+45.1%
0.00%
+100.0%
Q1 2014$48,0000.0%14,4700.0%0.00%0.0%
Q4 2013$48,000
+269.2%
14,470
+223.7%
0.00%
Q3 2013$13,0004,4700.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders